Zhifei Biotech: Lyophilized rabies vaccine for humans approved for clinical trials
2026-11-13 16:51:58
According to CoinMeta, Zhifei Biology announced that the lyophilized human rabies vaccine developed by its wholly-owned subsidiary, Zhifei Longcomma, has been approved for clinical trials by the National Medical Products Administration, and they have agreed to conduct clinical trials for the prevention of rabies.
Bullish 0
Bearish 0Share to 
Source：Jin10 Data
This content is for market information only and does not constitute investment advice.
Follow WalletJYS official accounts to stay updated
Hot Articles
Refresh
NVIDIA's stock tumbles 9% after the latest announcement; what impact will NVIDIA's decline have on the AI industry?
11-12 16:08
SOL Currency's Latest Price Outlook: Can It Break Through the $90 Barrier?
11-11 11:59
Dow Jones 1,000-Point Swings: CPI Reversal or Bull Trap?
11-10 16:56
Coinbase Is the exchange safe? How can beginners in 2026 download and register?
11-09 19:09
$TRUMP Hits New Low, Down 30% , Can It Hold?
11-09 16:29
